Agenda

Return

C. 32

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	March 2, 2021

Contra

Costa

County

Subject:

Purchase Order with Becton Dickinson and Company

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 03/02/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Marcy Wilhelm Margaret Harris

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: March 2, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a Purchase Order with Becton Dickinson and Company, in an amount not to exceed $300,000 for the reagents and supplies, for the microbiology unit at the Contra Costa Regional Medical Center (CCRMC) clinical laboratory, for the period from December 21, 2020 through December 20, 2027.

FISCAL IMPACT:

This purchase order will result in services and supplies expenditures of up to $300,000 over a 7 year period and will be funded 100% by Hospital Enterprise Fund I revenues.

BACKGROUND:

The CCRMC clinical laboratory uses blood culturing as a tool in diagnosing sepsis, which is the number one cause of death in patients with COVID-19. Rapid diagnosis of a blood stream infection is the key in selecting the correct targeted antibiotic therapy to help the patient fight the infection. The rental of the Becton Dickinson and Company's BACTEC along with reagents and supplies that are needed to perform tests, will help improve the recovery of positive blood cultures as well as improve the time to detection of those organisms. The BD BACTEC is an improved and innovative platform compared to its competitors. It also has an improved and faster organism recovery which are two of the most popular platforms on the market.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, then CCRMC clinical laboratory will not be able to perform the specific patient testing that utilizes these supplies, thus impacting patient safety and health.